38 results
424B3
v08r34pbe
4 Apr 23
Prospectus supplement
4:57pm
POS AM
k4qc55lwvkvn
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
dol2l43wnw4t61slu
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B4
ynpubj5xfkb
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
8cqq258y79j2zp5z
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am